Preclinical Imaging Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Modality (Optical Imaging Systems, Nuclear Imaging Systems, Micro-MRI, Micro-ultrasound, Micro-CT, Photoacoustic Imaging Systems, Other), By Application (Research and Development, Drug Discovery), By End User (Biotechnology & Pharmaceutical Companies, Academic & Research Institutes, Others), By Region and Competition, 2020-2030F
Market Overview
The Global Preclinical Imaging Market was valued at USD 5.13 billion in 2024 and is projected treach USD 7.27 billion by 2030, growing at a CAGR of 5.94% during the forecast period. Preclinical imaging is a critical component of biomedical research, offering non-invasive techniques tvisualize and monitor biological processes in animal models. This enables scientists tstudy disease progression, evaluate drug efficacy, and develop personalized medicine strategies. The market is expanding rapidly due trising investment in drug discovery, increasing demand for early-stage disease research, and the growing prevalence of chronic conditions. Modalities such as MRI, PET, CT, and optical imaging play a central role in these applications. The integration of imaging technologies and advancements in imaging resolution and data analysis are further enhancing research capabilities. Increased global awareness of the value of preclinical imaging in accelerating medical innovation is expected tsustain strong market momentum over the forecast period.
Key Market Drivers
Imagine having the ability twitness disease progression, drug efficacy, and the intricate details of biological processes without invasive procedures.
This is the transformative promise of preclinical imaging. Techniques such as MRI, PET, and CT scans offer unparalleled insights intdisease mechanisms, treatment effects, and biological responses in real time. These technologies have become indispensable tools across medical research fields, including oncology, cardiology, and neurology. Their utility in visualizing tissue response and pharmacokinetics contributes tfaster and more effective drug development. As the demand for targeted therapies and personalized medicine grows, sdoes the reliance on sophisticated imaging systems that can provide early and accurate biological assessments, propelling the growth of the preclinical imaging market globally.
Key Market Challenges
Cost of Technology and Infrastructure
The high cost of acquiring, maintaining, and operating advanced imaging equipment remains a significant barrier in the preclinical imaging space. Technologies like MRI, PET, and CT scanners involve substantial capital investment, which can be prohibitive for small and mid-sized research facilities. Additionally, ongoing maintenance, software upgrades, and the need for highly skilled personnel add tthe financial burden. According ta 2024 NIH report, over 45% of life science laboratories identified training and equipment maintenance as major financial challenges. These cost-related issues can limit access tcutting-edge imaging tools, thereby constraining innovation and adoption in emerging and resource-limited markets.
Key Market Trends
Multi-Modal Imaging Integration
A key trend in the Global Preclinical Imaging Market is the growing adoption of multi-modal imaging systems. By integrating technologies like MRI, PET, CT, and optical imaging, researchers can simultaneously obtain anatomical, functional, and molecular data. Each modality offers unique strengths: for example, MRI provides high-resolution anatomical detail, while PET allows for the visualization of metabolic processes. The combination of these approaches enables a more comprehensive analysis, improving the depth and accuracy of preclinical studies. As integration technology becomes more cost-effective and accessible, multi-modal imaging is expected tbecome a standard in research environments seeking tmaximize data quality and operational efficiency.
Key Market Players
In this report, the Global Preclinical Imaging Market has been segmented intthe following categories, in addition tthe industry trends which have alsbeen detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Preclinical Imaging Market.
Available Customizations
Global Preclinical Imaging Market report with the given market data, TechSci Research offers customizations according ta company's specific needs. The following customization options are available for the report:
Company Information
The Global Preclinical Imaging Market was valued at USD 5.13 billion in 2024 and is projected treach USD 7.27 billion by 2030, growing at a CAGR of 5.94% during the forecast period. Preclinical imaging is a critical component of biomedical research, offering non-invasive techniques tvisualize and monitor biological processes in animal models. This enables scientists tstudy disease progression, evaluate drug efficacy, and develop personalized medicine strategies. The market is expanding rapidly due trising investment in drug discovery, increasing demand for early-stage disease research, and the growing prevalence of chronic conditions. Modalities such as MRI, PET, CT, and optical imaging play a central role in these applications. The integration of imaging technologies and advancements in imaging resolution and data analysis are further enhancing research capabilities. Increased global awareness of the value of preclinical imaging in accelerating medical innovation is expected tsustain strong market momentum over the forecast period.
Key Market Drivers
Imagine having the ability twitness disease progression, drug efficacy, and the intricate details of biological processes without invasive procedures.
This is the transformative promise of preclinical imaging. Techniques such as MRI, PET, and CT scans offer unparalleled insights intdisease mechanisms, treatment effects, and biological responses in real time. These technologies have become indispensable tools across medical research fields, including oncology, cardiology, and neurology. Their utility in visualizing tissue response and pharmacokinetics contributes tfaster and more effective drug development. As the demand for targeted therapies and personalized medicine grows, sdoes the reliance on sophisticated imaging systems that can provide early and accurate biological assessments, propelling the growth of the preclinical imaging market globally.
Key Market Challenges
Cost of Technology and Infrastructure
The high cost of acquiring, maintaining, and operating advanced imaging equipment remains a significant barrier in the preclinical imaging space. Technologies like MRI, PET, and CT scanners involve substantial capital investment, which can be prohibitive for small and mid-sized research facilities. Additionally, ongoing maintenance, software upgrades, and the need for highly skilled personnel add tthe financial burden. According ta 2024 NIH report, over 45% of life science laboratories identified training and equipment maintenance as major financial challenges. These cost-related issues can limit access tcutting-edge imaging tools, thereby constraining innovation and adoption in emerging and resource-limited markets.
Key Market Trends
Multi-Modal Imaging Integration
A key trend in the Global Preclinical Imaging Market is the growing adoption of multi-modal imaging systems. By integrating technologies like MRI, PET, CT, and optical imaging, researchers can simultaneously obtain anatomical, functional, and molecular data. Each modality offers unique strengths: for example, MRI provides high-resolution anatomical detail, while PET allows for the visualization of metabolic processes. The combination of these approaches enables a more comprehensive analysis, improving the depth and accuracy of preclinical studies. As integration technology becomes more cost-effective and accessible, multi-modal imaging is expected tbecome a standard in research environments seeking tmaximize data quality and operational efficiency.
Key Market Players
- Aspect Imaging Ltd
- Bruker Corporation
- Fujifilm Holdings Corporation
- MedisLtd
- MR Solutions Ltd
- PerkinElmer Inc.
- United Imaging Healthcare Co. Ltd
- AXT PTY LTD
- Advanced Molecular Vision, Inc.
- IVIM Technology Corp
In this report, the Global Preclinical Imaging Market has been segmented intthe following categories, in addition tthe industry trends which have alsbeen detailed below:
- Preclinical Imaging Market, By Modality:
- Optical Imaging Systems
- Nuclear Imaging Systems
- Micro-MRI
- Micro-ultrasound
- Micro-CT
- Photoacoustic Imaging Systems
- Other
- Preclinical Imaging Market, By Application:
- Research and Development
- Drug Discovery
- Preclinical Imaging Market, By End User:
- Biotechnology & Pharmaceutical Companies
- Academic & Research Institutes
- Others
- Preclinical Imaging Market, By Region:
- North America
- United States
- Canada
- Mexico
- Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
- Asia-Pacific
- China
- India
- Japan
- Australia
- South Korea
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
Company Profiles: Detailed analysis of the major companies present in the Global Preclinical Imaging Market.
Available Customizations
Global Preclinical Imaging Market report with the given market data, TechSci Research offers customizations according ta company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up tfive).
1. PRODUCT OVERVIEW
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. RESEARCH METHODOLOGY
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. EXECUTIVE SUMMARY
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. VOICE OF CUSTOMER
5. GLOBAL PRECLINICAL IMAGING MARKET OUTLOOK
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Modality (Optical Imaging Systems, Nuclear Imaging Systems, Micro-MRI, Micro-ultrasound, Micro-CT, Photoacoustic Imaging Systems, Other)
5.2.2. By Application (Research and Development, Drug Discovery)
5.2.3. By End User (Biotechnology & Pharmaceutical Companies, Academic & Research Institutes, Others)
5.2.4. By Region
5.2.5. By Company (2024)
5.3. Market Map
6. NORTH AMERICA PRECLINICAL IMAGING MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Modality
6.2.2 By Application
6.2.3. By End User
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Preclinical Imaging Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Modality
6.3.1.2.2. By Application
6.3.1.2.3. By End User
6.3.2. Canada Preclinical Imaging Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Modality
6.3.2.2.2. By Application
6.3.2.2.3. By End User
6.3.3. Mexico Preclinical Imaging Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Modality
6.3.3.2.2. By Application
6.3.3.2.3. By End User
7. EUROPE PRECLINICAL IMAGING MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Modality
7.2.2. By Application
7.2.3. By End User
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Preclinical Imaging Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Modality
7.3.1.2.2. By Application
7.3.1.2.3. By End User
7.3.2. United Kingdom Preclinical Imaging Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Modality
7.3.2.2.2. By Application
7.3.2.2.3. By End User
7.3.3. Italy Preclinical Imaging Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecasty
7.3.3.2.1. By Modality
7.3.3.2.2. By Application
7.3.3.2.3. By End User
7.3.4. France Preclinical Imaging Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Modality
7.3.4.2.2. By Application
7.3.4.2.3. By End User
7.3.5. Spain Preclinical Imaging Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Modality
7.3.5.2.2. By Application
7.3.5.2.3. By End User
8. ASIA-PACIFIC PRECLINICAL IMAGING MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Modality
8.2.2. By Application
8.2.3. By End User
8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Preclinical Imaging Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Modality
8.3.1.2.2. By Application
8.3.1.2.3. By End User
8.3.2. India Preclinical Imaging Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Modality
8.3.2.2.2. By Application
8.3.2.2.3. By End User
8.3.3. Japan Preclinical Imaging Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Modality
8.3.3.2.2. By Application
8.3.3.2.3. By End User
8.3.4. South Korea Preclinical Imaging Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Modality
8.3.4.2.2. By Application
8.3.4.2.3. By End User
8.3.5. Australia Preclinical Imaging Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Modality
8.3.5.2.2. By Application
8.3.5.2.3. By End User
9. SOUTH AMERICA PRECLINICAL IMAGING MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Modality
9.2.2. By Application
9.2.3. By End User
9.2.4. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Preclinical Imaging Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Modality
9.3.1.2.2. By Application
9.3.1.2.3. By End User
9.3.2. Argentina Preclinical Imaging Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Modality
9.3.2.2.2. By Application
9.3.2.2.3. By End User
9.3.3. Preclinical Imaging Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Modality
9.3.3.2.2. By Application
9.3.3.2.3. By End User
10. MIDDLE EAST AND AFRICA PRECLINICAL IMAGING MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Modality
10.2.1 By Application
10.2.2.By End User
10,2,2, BY COUNTRY
10.3. MEA: Country Analysis
10.3.1. South Africa Preclinical Imaging Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Modality
10.3.1.2.2. By Application
10.3.1.2.3. By End User
10.3.2. Saudi Arabia Preclinical Imaging Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Modality
10.3.2.2.2. By Application
10.3.2.2.3. By End User
10.3.3. UAE Preclinical Imaging Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Modality
10.3.3.2.2. By Application
10.3.3.2.3. By End User
11. MARKET DYNAMICS
11.1. Drivers
11.2. Challenges
12. MARKET TRENDS & DEVELOPMENTS
12.1. Recent Developments
12.2. Product Launches
12.3. Mergers & Acquisitions
13. GLOBAL PRECLINICAL IMAGING MARKET: SWOT ANALYSIS
14. COMPETITIVE LANDSCAPE
14.1. Aspect Imaging Ltd
14.1.1. Business Overview
14.1.2. Company Snapshot
14.1.3. Products & Services
14.1.4. Financials (As Reported)
14.1.5. Recent Developments
14.1.6. Key Personnel Details
14.1.7. SWOT Analysis
14.2. Bruker Corporation
14.3. Fujifilm Holdings Corporation
14.4. Mediso Ltd
14.5. MR Solutions Ltd
14.6. PerkinElmer Inc.
14.7. United Imaging Healthcare Co. Ltd
14.8. AXT PTY LTD
14.9. Advanced Molecular Vision, Inc.
14.10 IVIM Technology Corp.Inc.
15. STRATEGIC RECOMMENDATIONS
16. ABOUT US & DISCLAIMER
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. RESEARCH METHODOLOGY
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. EXECUTIVE SUMMARY
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. VOICE OF CUSTOMER
5. GLOBAL PRECLINICAL IMAGING MARKET OUTLOOK
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Modality (Optical Imaging Systems, Nuclear Imaging Systems, Micro-MRI, Micro-ultrasound, Micro-CT, Photoacoustic Imaging Systems, Other)
5.2.2. By Application (Research and Development, Drug Discovery)
5.2.3. By End User (Biotechnology & Pharmaceutical Companies, Academic & Research Institutes, Others)
5.2.4. By Region
5.2.5. By Company (2024)
5.3. Market Map
6. NORTH AMERICA PRECLINICAL IMAGING MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Modality
6.2.2 By Application
6.2.3. By End User
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Preclinical Imaging Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Modality
6.3.1.2.2. By Application
6.3.1.2.3. By End User
6.3.2. Canada Preclinical Imaging Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Modality
6.3.2.2.2. By Application
6.3.2.2.3. By End User
6.3.3. Mexico Preclinical Imaging Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Modality
6.3.3.2.2. By Application
6.3.3.2.3. By End User
7. EUROPE PRECLINICAL IMAGING MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Modality
7.2.2. By Application
7.2.3. By End User
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Preclinical Imaging Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Modality
7.3.1.2.2. By Application
7.3.1.2.3. By End User
7.3.2. United Kingdom Preclinical Imaging Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Modality
7.3.2.2.2. By Application
7.3.2.2.3. By End User
7.3.3. Italy Preclinical Imaging Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecasty
7.3.3.2.1. By Modality
7.3.3.2.2. By Application
7.3.3.2.3. By End User
7.3.4. France Preclinical Imaging Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Modality
7.3.4.2.2. By Application
7.3.4.2.3. By End User
7.3.5. Spain Preclinical Imaging Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Modality
7.3.5.2.2. By Application
7.3.5.2.3. By End User
8. ASIA-PACIFIC PRECLINICAL IMAGING MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Modality
8.2.2. By Application
8.2.3. By End User
8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Preclinical Imaging Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Modality
8.3.1.2.2. By Application
8.3.1.2.3. By End User
8.3.2. India Preclinical Imaging Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Modality
8.3.2.2.2. By Application
8.3.2.2.3. By End User
8.3.3. Japan Preclinical Imaging Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Modality
8.3.3.2.2. By Application
8.3.3.2.3. By End User
8.3.4. South Korea Preclinical Imaging Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Modality
8.3.4.2.2. By Application
8.3.4.2.3. By End User
8.3.5. Australia Preclinical Imaging Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Modality
8.3.5.2.2. By Application
8.3.5.2.3. By End User
9. SOUTH AMERICA PRECLINICAL IMAGING MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Modality
9.2.2. By Application
9.2.3. By End User
9.2.4. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Preclinical Imaging Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Modality
9.3.1.2.2. By Application
9.3.1.2.3. By End User
9.3.2. Argentina Preclinical Imaging Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Modality
9.3.2.2.2. By Application
9.3.2.2.3. By End User
9.3.3. Preclinical Imaging Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Modality
9.3.3.2.2. By Application
9.3.3.2.3. By End User
10. MIDDLE EAST AND AFRICA PRECLINICAL IMAGING MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Modality
10.2.1 By Application
10.2.2.By End User
10,2,2, BY COUNTRY
10.3. MEA: Country Analysis
10.3.1. South Africa Preclinical Imaging Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Modality
10.3.1.2.2. By Application
10.3.1.2.3. By End User
10.3.2. Saudi Arabia Preclinical Imaging Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Modality
10.3.2.2.2. By Application
10.3.2.2.3. By End User
10.3.3. UAE Preclinical Imaging Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Modality
10.3.3.2.2. By Application
10.3.3.2.3. By End User
11. MARKET DYNAMICS
11.1. Drivers
11.2. Challenges
12. MARKET TRENDS & DEVELOPMENTS
12.1. Recent Developments
12.2. Product Launches
12.3. Mergers & Acquisitions
13. GLOBAL PRECLINICAL IMAGING MARKET: SWOT ANALYSIS
14. COMPETITIVE LANDSCAPE
14.1. Aspect Imaging Ltd
14.1.1. Business Overview
14.1.2. Company Snapshot
14.1.3. Products & Services
14.1.4. Financials (As Reported)
14.1.5. Recent Developments
14.1.6. Key Personnel Details
14.1.7. SWOT Analysis
14.2. Bruker Corporation
14.3. Fujifilm Holdings Corporation
14.4. Mediso Ltd
14.5. MR Solutions Ltd
14.6. PerkinElmer Inc.
14.7. United Imaging Healthcare Co. Ltd
14.8. AXT PTY LTD
14.9. Advanced Molecular Vision, Inc.
14.10 IVIM Technology Corp.Inc.
15. STRATEGIC RECOMMENDATIONS
16. ABOUT US & DISCLAIMER
